

H-Optimus-1 is a state-of-the-art foundation model developed by Bioptimus, designed to revolutionize histological analysis in biomedical research and diagnostics. By leveraging a vast and diverse dataset of over one million whole-slide images from more than 800,000 patients, H-Optimus-1 captures complex histological patterns across various tissue types and pathological conditions. This extensive training enables the model to generate powerful embeddings that serve as a robust backbone for a wide range of digital pathology applications.

M-Optimus is a cutting-edge, multi-modal, multi-scale foundation model designed to revolutionize biological research by integrating diverse biological data types across various scales. Unlike traditional AI models that focus on a single modality—such as genetics, single-cell data, or histology—M-Optimus bridges these areas, capturing the complex interplay between tissue morphology and gene expression. This holistic approach enables a more comprehensive understanding of biological systems, facilitating faster drug discovery, more precise diagnostics, and groundbreaking biomedical discoveries.

Bioptimus is pioneering the development of the first universal AI foundation model for biology, aiming to revolutionize scientific research and biotechnological innovation. By integrating advanced artificial intelligence with comprehensive biological data, Bioptimus seeks to uncover complex biological mechanisms, thereby accelerating discoveries in biomedicine and related fields.
Bioptimus is a company specializing in the development and production of innovative nutritional supplements and health products. The vendor focuses on optimizing health through scientifically-backed formulations that aim to enhance well-being and support various health needs. Bioptimus emphasizes quality and efficacy in its product offerings, catering to a diverse range of consumers seeking to improve their health and lifestyle.